Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

67%

4 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3

3(60.0%)

N/A

1(20.0%)

Phase 4

1(20.0%)

5Total

Phase 3(3)

N/A(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT03652883Not ApplicableCompleted

ImpleMentAll - Towards Evidence-based Tailored Implementation Strategies for eHealth

Role: collaborator

NCT03787433Completed

Assisted Rehabilitation Care During Post-stroke mANaGement: fEasibiLity Assessment

Role: collaborator

NCT00235079Phase 4Completed

Study of Colchicine to Treat and Prevent Recurrent Pericarditis After Failure of Conventional Treatment.

Role: lead

NCT00128453Phase 3Completed

Study of Colchicine to Treat Acute Pericarditis and Prevent Recurrences

Role: lead

NCT00128414Phase 3Completed

Study of Colchicine to Treat and Prevent Recurrent Pericarditis (First Episode)

Role: lead

NCT00128427Phase 3Completed

Study of Colchicine to Prevent the Postpericardiotomy Syndrome

Role: lead

All 6 trials loaded